(Q24610145)

2

Yukiko

Kimura

1 reference

29 November 2023

Peter A Nigrovic

4

Peter A

Nigrovic

1 reference

29 November 2023

Karen Onel

5

Karen

Onel

1 reference

29 November 2023

Rayfel Schneider

7

Rayfel

Schneider

1 reference

29 November 2023

Matthew L Stoll

8

Matthew L

Stoll

1 reference

29 November 2023

Diana Milojevic

10

Diana

Milojevic

1 reference

29 November 2023

Richard K Vehe

12

Richard K

Vehe

1 reference

29 November 2023

Jennifer E Weiss

13

Jennifer E

Weiss

1 reference

29 November 2023

Pamela Weiss

14

Pamela

Weiss

1 reference

29 November 2023

Norman T Ilowite

15

Norman T

Ilowite

1 reference

29 November 2023

Carol A Wallace

16

Carol A

Arthritis Care and Research

Wallace

1 reference

29 November 2023

language of work or name

English

0 references

publication date

July 2012

0 references

published in

0 references

volume

64

0 references

issue

7

0 references

page(s)

1001-10

0 references

cites work

2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3368104

Evaluation of clinical measures and different criteria for diagnosis of adult-onset Still's disease in a Chinese population

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3368104

Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: report of forty-six patients from an international multicenter series

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3368104

A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3368104

Anakinra for systemic juvenile arthritis: the Rocky Mountain experience

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3368104

Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3368104

Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3368104

Evaluation of the presentation of systemic onset juvenile rheumatoid arthritis: data from the Pennsylvania Systemic Onset Juvenile Arthritis Registry (PASOJAR).

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3368104

Predictors of disease course and remission in systemic juvenile idiopathic arthritis: significance of early clinical and laboratory features

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3368104

Use of infliximab in patients with systemic juvenile idiopathic arthritis refractory to etanercept.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3368104

Preliminary diagnostic guidelines for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3368104

The German etanercept registry for treatment of juvenile idiopathic arthritis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3368104

Long-term follow-up of 246 adults with juvenile idiopathic arthritis: functional outcome

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3368104

Early predictors of poor functional outcome in systemic-onset juvenile rheumatoid arthritis: a multicenter cohort study

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3368104

Preliminary criteria for classification of adult Still's disease

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3368104

Comparative effectiveness research: a report from the Institute of Medicine.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3368104

Etanercept treatment in patients with refractory systemic onset juvenile rheumatoid arthritis.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3368104

Systemic onset juvenile idiopathic arthritis: a retrospective study of 80 consecutive patients followed for 10 years.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3368104

Prognosis in juvenile chronic arthritis. Follow-up of 433 chronic rheumatic children

28 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22290637

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Prognostic indicators of joint destruction in systemic-onset juvenile rheumatoid arthritis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22290637

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Global damage in systemic juvenile idiopathic arthritis: preliminary early predictors

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22290637